COREX at ACTO Logistics Committee

COREX at ACTO Logistics Committee
COREX team members were invited to a meeting of the Association of Clinical Trials Organizations (ACTO) Logistics Committee that was held in August. During a lively debate, a vital for the pharmaceutical industry initiation of new medicinal products’ labeling protocols and procedures in the Russian Federation was addressed.

In the course of the meeting several questions about the turnover of drugs and their withdrawal from circulation were discussed; another important matter that sparked an exchange of opinions had to do with the amount of responsibility that would fall on organizations that manage these activities. COREX’ quality director, Vitaly Shakhnazarov, spoke about our company’s approach to handling of drug labeling. It is worth mentioning that the proposed solutions have been designed to address the changes in labeling in a cost-conscious manner.

The panel had concluded that at present time some of the issues with the upcoming changes in drug labeling reform have more questions than answers and that an ongoing dialogue with the regulatory bodies to address perceived limitations is paramount.
Back to the list

Industry insights

Ethics committees

Ethics committee supervision is a vital part of all clinical trials.

Russia's first stem cell-based medica...

On March 12, the Russian Ministry of Health granted approval for clinical trials to test the efficacy of the country's first stem cell-based product for knee cartilage replacement.


We’re here to help.
Email us at or use our feedback form to send us your question.

This website uses cookies to improve user experience. By using our website you consent to all cookies in accordance with our Cookie Policy. Read More.